Fidelity Investments’s Immune Design Corp. IMDZ Stock Holding History

Fidelity Investments’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,426	Closed	-$2K	–	4561
2018 Q4	$2K	Sell	1,426 -463,831	-100%	-$806K	﹤0.01%	3368
2018 Q3	$1.6M	Sell	465,257 -719,235	-61%	-$2.7M	﹤0.01%	2407
2018 Q2	$5.39M	Hold	1,184,492	–	–	﹤0.01%	2128
2018 Q1	$3.91M	Sell	1,184,492 -400	-0%	-$1.42K	﹤0.01%	2238
2017 Q4	$4.62M	Buy	1,184,892 +686,500	+138%	+$3.74M	﹤0.01%	2184
2017 Q3	$5.16M	Buy	498,392 +87,051	+21%	+$857K	﹤0.01%	2151
2017 Q2	$4.01M	Sell	411,341 -33,811	-8%	-$237K	﹤0.01%	2215
2017 Q1	$3.03M	Buy	445,152 +1,699	+0.4%	+$9.82K	﹤0.01%	2276
2016 Q4	$2.44M	Sell	443,453 -60,226	-12%	-$425K	﹤0.01%	2342
2016 Q3	$3.82M	Sell	503,679 -230,962	-31%	-$1.69M	﹤0.01%	2253
2016 Q2	$6M	Sell	734,641 -728,143	-50%	-$9.08M	﹤0.01%	2138
2016 Q1	$19M	Sell	1,462,784 -117,257	-7%	-$1.35M	﹤0.01%	1683
2015 Q4	$31.7M	Hold	1,580,041	–	–	﹤0.01%	1454
2015 Q3	$19.3M	Hold	1,580,041	–	–	﹤0.01%	1672
2015 Q2	$32.6M	Buy	1,580,041 +723,600	+84%	+$17.1M	﹤0.01%	1530
2015 Q1	$18.1M	Buy	856,441 +37,677	+5%	+$983K	﹤0.01%	1761
2014 Q4	$25.2M	Sell	818,764 -81,236	-9%	-$2.26M	﹤0.01%	1639
2014 Q3	$15.9M	Buy	+900,000	New	+$11.4M	﹤0.01%	1848

Other funds holding IMDZ

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

SAM

Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Fidelity Investments's IMDZ Position: Q1 2019 in Review

Fidelity Investments sold out of Immune Design Corp. (IMDZ) in Q1 2019, closing a stake of 1,426 shares — an estimated $2K sold.

Fidelity Investments first reported a position in IMDZ in Q3 2014 and held it in 18 quarters. The position peaked at $32.6M in Q2 2015. 68 funds tracked by Wall St. Rank hold IMDZ as of Q1 2019.

Fidelity Investments reported no remaining Immune Design Corp. position as of Q1 2019 after selling out during the quarter.
Fidelity Investments sold 1,426 Immune Design Corp. shares in Q1 2019, an estimated $2K.
Fidelity Investments first reported a position in Immune Design Corp. in Q3 2014 and held it in 18 quarters.
Fidelity Investments's Immune Design Corp. position peaked at $32.6M in Q2 2015.
68 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2019.

Based on Fidelity Investments's 13F filing for Q1 2019, filed 13 May 2019.